following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
.
marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
.
.
when bruschi suffered a stroke in 2005, he was treated at massachusetts general hospital, which he said was well equipped to handle the medical emergency.
.
hammond makes brexit promise to financial services
.
.
.
.